QT
QNCX icon

Quantamental Technologies’s Quince Therapeutics QNCX Stock Holding History

Quantamental Technologies’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-54
Closed -$17K – 613
2023
Q1 		$17K Sell
54
-5
-8% -$978 0.01% 406
2022
Q4 		$7.5K Hold
59
– – ﹤0.01% 434
2022
Q3 		$16K Sell
59
-2
-3% -$762 0.01% 477
2022
Q2 		$27K Sell
61
-2
-3% -$1.41K 0.01% 398
2022
Q1 		$78K Sell
63
-3
-5% -$4.08K 0.05% 347
2021
Q4 		$167K Buy
+66
New +$403K 0.08% 346

Other funds holding QNCX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KAM
Knightsbridge Asset Management Newport Beach, California $743M AUM 28.33% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantamental Technologies's QNCX Position: Q2 2023 in Review

Quantamental Technologies sold out of Quince Therapeutics (QNCX) in Q2 2023, closing a stake of 54 shares — an estimated $17K sold.

Quantamental Technologies first reported a position in QNCX in Q4 2021 and held it in 6 quarters. The position peaked at $167K in Q4 2021. 38 funds tracked by Wall St. Rank hold QNCX as of Q2 2023.

  • Quantamental Technologies reported no remaining Quince Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Quantamental Technologies sold 54 Quince Therapeutics shares in Q2 2023, an estimated $17K.
  • Quantamental Technologies first reported a position in Quince Therapeutics in Q4 2021 and held it in 6 quarters.
  • Quantamental Technologies's Quince Therapeutics position peaked at $167K in Q4 2021.
  • 38 funds tracked by Wall St. Rank held Quince Therapeutics as of Q2 2023.

Based on Quantamental Technologies's 13F filing for Q2 2023, filed 14 Aug 2023.